Cover Image
市場調查報告書

中國的醫院產業:2015年∼2018年

China Hospital Industry Report, 2015-2018

出版商 ResearchInChina 商品編碼 272314
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的醫院產業:2015年∼2018年 China Hospital Industry Report, 2015-2018
出版日期: 2015年11月11日 內容資訊: 英文 156 Pages
簡介

中國的醫院數,由於需求推動,從2011年的21,979到2015年5月末的26,479,整體增加了4,500。明細中,公立醫院整體減少,私立醫院劇增。2011年∼2015年5月末之間,私立醫院數為4,713,佔有率從38.4%增加到49.7%。但,在收益方面,中國的私立醫院只佔10%。

本報告提供中國的醫院產業調查分析、產業概要、專門醫院現況、產業的發展預測、投資相關驗證、主要醫院簡介等系統性資訊。

第1章 中國的醫院產業概要

  • 定義
  • 分類
  • 產業鏈

第2章 中國的醫院產業的發展

  • 概要
  • 收益
  • 醫療服務
  • 競爭格局
  • 摘要與預測

第3章 中國的專門醫院的發展

  • 概要
  • 各種專門醫院現況

第4章 中國的醫院產業的發展預測

  • 中國的醫療保險現況
  • 都市化的醫院產業的發展

第5章 中國的醫院產業的投資

  • 政策的推動力
  • 公立醫院 vs. 私立醫院
  • 社會資本的投資機會
  • 外資醫院發展的方向性與經營模式

第6章 中國的主要私立醫院

  • 簡介、經營、收益結構、毛利等
    • Aier Eye Hospital Group
    • TC Medical
    • Mayinglong Pharm
    • Shanghai Fosun Pharmaceutical (Group)
    • Jinling Pharmaceutical Company Limited
    • Shinva Medical
    • Xi'an International Medical Investment Co., Ltd.
    • Inner Mongolia Furui Medical Science
    • Wuhan Jianmin Pharmaceutical Groups Corp.
    • Concord Medical Services Holdings Limited
    • Phoenix Healthcare Group
    • Guizhou Yibai Pharmaceutical
    • Kangmei Pharmaceutica
    • JNMPT
    • China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
    • Parkway Pantai

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ZLC026

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decline whereas private hospitals increased rapidly.

During the period from 2011 to late May2015, the number of private hospitals in China advanced 4,713, with the share up from 38.4% to 49.7%. But in point of revenue, China's private hospitals just accounted for 10%.

In terms of medical service, between January and May 2015, China saw 1.2152 billion hospital visits, up 5.4% from a year earlier. Although the number of public hospitals occupied only 50.3% of total hospitals, yet the public hospital visits represented up to 89.1%, which was mainly due to the fact that private hospitals are small in scale and have relatively poor treatment level and lower public awareness.

At present, more investment has gone to specialized hospitals, which have captured long-term attention from social capital, hence a great market demand. As of the end of 2014, the number of specialized hospitals in China were expected to reach 5,449, making up 21.4% of the total. Among them, mental hospitals, maternity hospitals, orthopaedic hospitals, stomatological hospitals, and ophthalmic hospitals constitute the mainstay. Tumor hospitals generated the most revenue while beauty hospitals, ophthalmic hospitals, and stomatological hospitals produced relatively higher profit margin.

In recent years, the State has introduced a series of favorable policies designed to encourage private capital into the hospital industry, thus setting off a wave of social capital inrush to medical service. Currently, many private companies including Aier Eye Hospital Group, TC Medical, Mayinglong Pharm, Shanghai Fosun Pharmaceutical (Group), Jinling Pharmaceutical Company Limited, and Phoenix Healthcare Group have ventured into the field of medical service. Among them, Aier Eye Hospital Group and Shanghai Fosun Pharmaceutical (Group) achieved good results in business development. In H1 2015, the medical service revenue for the two companies totaled RMB1.175 billion and RMB674.4 million, respectively.

As China's largest ophthalmic medical chain institution, Aier Eye Hospital Group have established more than 100 professional ophthalmic hospitals throughout the country, with over 3 million outpatient visits annually. In the past two years, the company set up four industrial merger & acquisition funds used to invest in grand health industry, in the hope of increasing hospital outlets and achieving industrial expansion. ? Fosun Pharma specializes in drug manufacturing and research and development meanwhile operating medical service business. In recent years, through self-building, mergers and acquisitions, joint venturing, and affiliation, the company has made continuous expansion in medical service and seen explosive growth in revenue from this field. In 2011-2014, the company's medical service revenue registered a CAGR of 371.5%. In 2014, the company participated in the privatization of Chindex International, Inc. ("Chindex"), and upon the completion of the privatization transaction, Fosun Industrial held a 42.927% equity interest and at the same time owned "United Family Hospital", a high-end brand for healthcare services under Chindex.

image1

The report highlights the followings:

  • Overview of China hospital industry, including number of hospitals, revenue, medical service, competition pattern, summary and forecast, etc.;
  • Status quo of specialized hospitals in China, including overall operation, development of specialized hospitals of all sorts, etc.;
  • Development prediction of China hospital industry, including the impact of medical insurance system and urbanization on hospital industry, etc.;
  • Investment in China hospital industry, including related policies, comparison of public and private hospitals, investment opportunities of social capital, and development model of foreign-funded hospitals, etc.;
  • Operation, and medical service business of 16 enterprises venturing into hospital industry.

Table of Contents

1. Overview of China Hospital Industry

  • 1.1 Definition
  • 1.2 Classification
  • 1.3 Industry Chain

2. Development of China Hospital Industry

  • 2.1 Overview
    • 2.1.1 Number of Hospitals
    • 2.1.2 Distribution
  • 2.2 Revenue
    • 2.2.1 Total Revenue
    • 2.2.2 General Hospitals
  • 2.3 Medical Service
  • 2.4 Competition Pattern
  • 2.5 Summary and Forecast

3. Development of Specialized Hospitals in China

  • 3.1 Overview
    • 3.1.1 Number of Hospitals
    • 3.1.2 Revenue
  • 3.2 Status Quo of Specialized Hospitals of All Kinds
    • 3.2.1 Ophthalmic Hospital
    • 3.2.2 Stomatological Hospital
    • 3.2.3 Orthopedics & Beauty Hospital
    • 3.2.4 Maternity Hospital Obstetrics and Gynecology Hospital
    • 3.2.5 Children's Hospital
    • 3.2.6 Tumor Hospital

4. Development Forecast of China Hospital Industry

  • 4.1 Status Quo of China Medical Insurance
    • 4.1.1 Medical Insurance System
    • 4.1.2 Medical Insurance Close to Saturation
    • 4.1.3 Medical Insurance for Serious Illness of Urban and Rural Residents
  • 4.2 Urbanization Bolsters Development of the Hospital Industry
    • 4.2.1 Status Quo of Urbanization in China
    • 4.2.2 Urbanization Expects to Optimize Medical Insurance System
    • 4.2.3 Trans-regional Medical Insurance Settlement is to be advanced
    • 4.2.4 Urbanization Incrementation Depends on the Contribution of Medical Insurance System
    • 4.2.5 Medical Insurance Fund Balance Rate Will See Further Decrease
    • 4.2.6 Medical Resource Supply of County-Level Hospitals Will Improve
    • 4.2.7 Urbanization Will Encourage Central Government to Invest in Urban Medical Resources

5. Investment in China Hospital Industry

  • 5.1 Impetus Given by Policies
  • 5.2 Comparison of Public and Private Hospitals
    • 5.2.1 Public Hospitals Play a Leading Role
    • 5.2.2 Private Hospitals Run with Efficiency
  • 5.3 Investment Opportunities of Social Capital
    • 5.3.1 Specialized Medical Field
    • 5.3.2 General Public Hospitals
  • 5.4 Development Orientation and Business Model of Foreign Hospitals
    • 5.4.1 Status Quo of Foreign Hospitals in China
    • 5.4.2 Development Direction
    • 5.4.3 Business Practice

6. Major Private Hospitals in China

  • 6.1 Aier Eye Hospital Group
    • 6.1.1 Profile
    • 6.1.2 Operation
    • 6.1.3 Revenue Structure
    • 6.1.4 Gross Margin
    • 6.1.5 R&D and Investment
    • 6.1.6 Medical Service
    • 6.1.7 Prediction and Outlook
  • 6.2 TC Medical
    • 6.2.1 Profile
    • 6.2.2 Operation
    • 6.2.3 Revenue Structure
    • 6.2.4 Gross Margin
    • 6.2.5 Medical Service
    • 6.2.6 Prediction and Outlook
  • 6.3 Mayinglong Pharm
    • 6.3.1 Profile
    • 6.3.2 Operation
    • 6.3.3 Revenue Structure
    • 6.3.4 Gross Margin
    • 6.3.5 R&D and Investment
    • 6.3.6 Medical Service
    • 6.3.7 Prediction and Outlook
  • 6.4 Shanghai Fosun Pharmaceutical (Group)
    • 6.4.1 Profile
    • 6.4.2 Operation
    • 6.4.3 Revenue Structure
    • 6.4.4 Gross Margin
    • 6.4.5 R&D and Investment
    • 6.4.6 Medical Service
    • 6.4.7 Prediction and Outlook
  • 6.5 Jinling Pharmaceutical Company Limited
    • 6.5.1 Profile
    • 6.5.2 Operation
    • 6.5.3 Revenue Structure
    • 6.5.4 Gross Margin
    • 6.5.5 R&D and Investment
    • 6.5.6 Medical Service
    • 6.5.7 Prediction and Outlook
  • 6.6 Shinva Medical
    • 6.6.1 Profile
    • 6.6.2 Operation
    • 6.6.3 Revenue Structure
    • 6.6.4 Gross Margin
    • 6.6.5 R&D and Investment
    • 6.6.6 Medical Service
    • 6.6.7 Prediction and Outlook
  • 6.7 Xi'an International Medical Investment Co., Ltd.
    • 6.7.1 Profile
    • 6.7.2 Operation
    • 6.7.3 Revenue Structure
    • 6.7.4 Medical Service
    • 6.7.5 Prediction and Outlook
  • 6.8 Inner Mongolia Furui Medical Science
    • 6.8.1 Profile
    • 6.8.2 Operation
    • 6.8.3 Revenue Structure
    • 6.8.4 Medical Service
    • 6.8.5 Prediction and Outlook
  • 6.9 Wuhan Jianmin Pharmaceutical Groups Corp.
    • 6.9.1 Profile
    • 6.9.2 Operation
    • 6.9.3 Revenue Structure
    • 6.9.4 Medical Service
    • 6.9.5 Prediction and Outlook
  • 6.10 Concord Medical Services Holdings Limited
    • 6.10.1 Profile
    • 6.10.2 Operation
    • 6.10.3 Medical Service
    • 6.10.4 Prediction and Outlook
  • 6.11 Phoenix Healthcare Group
    • 6.11.1 Profile
    • 6.11.2 Operation
    • 6.11.3 Medical Service
    • 6.11.4 Prediction and Outlook
  • 6.12 Guizhou Yibai Pharmaceutical
    • 6.12.1 Profile
    • 6.12.2 Operation
    • 6.12.3 Medical Service
    • 6.12.4 Prediction and Outlook
  • 6.13 Kangmei Pharmaceutical
    • 6.13.1 Profile
    • 6.13.2 Operation
    • 6.13.3 Medical Service
    • 6.13.4 Prediction and Outlook
  • 6.14 JNMPT
    • 6.14.1 Profile
    • 6.14.2 Operation
    • 6.14.3 Medical Service
    • 6.14.5 Prediction and Outlook
  • 6.15 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
    • 6.15.1 Profile
    • 6.15.2 Operation
    • 6.15.3 Medical Service
  • 6.16 Parkway Pantai
    • 6.16.1 Profile
    • 6.16.2 Development in China

Selected Charts

  • China's Hospital Industry Chain
  • Number and Increment of Hospitals in China, 2009-2015
  • Number of Hospitals in China by Level, 2009-2015
  • Percentage of Hospitals in China by Level as of the end of May 2015
  • Number of Hospitals in China by Economic Type, 2009-2015
  • Number of Hospitals in China by Economic Type, 2009-2015
  • Number of Hospitals in China by Type, 2009-2014
  • Number of Hospitals in China by Region as of the end of May 2015
  • Total Revenue and YoY Growth of Hospitals in China 2009-2014
  • Gross Margin of Hospitals in China, 2009-2014
  • Revenue Structure of China Hospital Industry by Source, 2013
  • Revenue Structure of China Hospital Industry by Type, 2013
  • Average Revenue and YoY Growth of General Hospitals in China 2009-2014
  • Average Revenue of Each General Hospital in China by Business, 2009-2013
  • Number of Visits to China's Hospitals, 2009-2015
  • Bed Utilization in China's Hospitals, 2009-2015
  • Number of Visits to China's Hospitals by Economic Type, 2012-2015
  • Structure of Chinese Hospital Visits by Economic Type, Jan.-May, 2015
  • Number of Visits to China's Hospitals by Hospital Level, 2012-2015
  • Structure of Chinese Hospital Visits by Hospital Level, Jan.-May, 2015
  • Bed Utilization in China's Hospitals by Hospital Level, 2009-2015
  • Proportion of Public Medical Institutions and Private Hospitals by Type, 2013
  • Medical Service Revenue of Major Private Hospitals in China, 2012-2015
  • Revenue of Major Chinese Private Hospitals, 2014-2018E
  • Number and Increment of Hospitals in China, 2014-2018E
  • Number of Specialized Hospitals and % of Total Hospitals in China, 2014-2018E
  • Revenue and YoY Growth of Hospitals in China, 2014-2018E
  • Revenue of Hospitals in China by Economic Type, 2014-2018E
  • Revenue from Specialized Hospitals and % of Total Revenue in China, 2014-2018E
  • Number of Specialized Hospitals and % of Total Hospitals in China, 2009-2014
  • Proportion of Specialized Hospitals in China by Economic Type, 2009-2014
  • Number of Specialized Hospitals in China by Type, 2010-2013
  • Proportion of Specialized Hospitals in China by Revenue, 2009-2014
  • Revenue from Specialized Hospitals in China by Type, 2010-2013
  • Operating Margin of Specialized Hospitals in China by Type, 2010-2013
  • Number of Ophthalmic Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Ophthalmic Hospitals in China, 2006-2013
  • Utilization of Hospital Beds and Service Efficiency of Doctors of Ophthalmic Hospitals in China, 2006-2013
  • Number of Stomatological Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Stomatological Hospitals in China, 2006-2013
  • Utilization of Hospital Beds and Workload of Doctors of Stomatological Hospitals in China, 2006-2013
  • Number and Distribution of Major Private Stomatological Medical Institutions and Their Chains in China, 2015
  • Plastic Surgery & Cosmetic Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Plastic Surgery & Cosmetic Hospitals in China, 2006-2013
  • Number of Maternity Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Maternity Hospitals in China, 2006-2013
  • Utilization of Hospital Beds and Workload of Doctors of Maternity Hospitals in China, 2006-2013
  • Number of Children's Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Children's Hospitals in China, 2006-2013
  • Utilization of Hospital Beds and Workload of Doctors of Children's Hospitals, 2006-2013
  • Number of Tumor Hospitals in China by Economic Type, 2009-2014
  • Total Revenue and Profits of Tumor Hospitals in China, 2006-2013
  • Utilization of Hospital Beds and Workload of Doctors of Tumor Hospitals in China, 2006-2013
  • Structure of Medical Insurance System in China
  • Population Covered under China's Urban Medical Insurance, 2008-2014
  • Urbanization Rate of China, 2000-2014
  • China's Healthcare Expenditure Structure, 2005-2014
  • Medical Insurances of China's Urban Workers and Balance Rate of New Rural Cooperative Medical System, 2005-2014
  • Favorable Polices on the Construction of County-Level Hospitals, 2009-2014
  • Landmark Events on Social Capitals Flowing to Medical Service Field in China, 1985-2014
  • Policies on Social Capitals Flowing to Medical Service Field in China, 2009-2015
  • Differences in Policies on China's Private and Public Hospitals
  • Entrustment Chain of Public Hospitals in China
  • Revenue and Market Share of Public Hospitals in China, 2008-2014
  • Revenue and Market Share of Private Hospitals in China, 2008-2014
  • Comparison of China's Major Medical Service-related Special projects
  • Trends towards Marketization of Medical Service System in China
  • Reform Mode of Established Property Rights System of Public Hospitals
  • Pilot Cases of China's Social Capitals Contributing to Public Hospital Restructuring, 1999-2015
  • Partners and Major Medical Treatment Services of Sino-Foreign Joint Ventures in China
  • Partners and Major Services of Sino-Foreign Joint Ventures in China
  • Revenue and Net Income of Aier Eye Hospital Group, 2011-2015
  • Net Income of Aier Eye Hospital Group's Major Subsidiaries , 2015H1
  • Revenue of Aier Eye Hospital Group by Business, 2009-2015
  • Revenue of Aier Eye Hospital Group by Region, 2009-2014
  • Revenue Structure of Aier Eye Hospital Group by Region, 2009-2014
  • Gross Margin of Aier Eye Hospital Group by Business,2009-2014
  • R&D Costs and % of Total Revenue of Aier Eye Hospital Group, 2012-2014
  • Medical Service Revenue and % of Total of Aier Eye Hospital Group, 2009-2015
  • Revenue and Net Income of Aier Eye Hospital Group, 2014-2018E
  • Revenue and Net Income of TC Medical, 2011-2015
  • Revenue of TC Medical by Business, 2012-2015
  • Revenue of TC Medical by Region, 2012-2015
  • Revenue Structure of TC Medical by Region, 2012-2015
  • Gross Margin of TC Medical, 2012-2015
  • Gross Margin of TC Medical by Business, 2012-2015
  • Client Orientation of TC Medical
  • Revenue and Net Income of TC Medical's Major Subsidiaries, 2013-2014
  • Revenue and Net Income of TC Medical, 2014-2018E
  • Revenue and Net Income of Mayinglong Pharm, 2011-2015
  • Revenue of Mayinglong Pharm by Product, 2012-2015
  • Revenue Structure of Mayinglong Pharm by Product, 2012-2015
  • Revenue of Mayinglong Pharm by Region, 2012-2015
  • Revenue Structure of Mayinglong Pharm by Region, 2012-2015
  • Gross Margin of Mayinglong Pharm by Product, 2012-2015
  • R&D Costs and % of Total Revenue of Mayinglong Pharm, 2012-2015
  • Key R&D Projects of Mayinglong Pharm, 2015
  • Establishment Mode and Equity Structure of Anorectum Hospitals under Mayinglong Pharm
  • Revenue and Net Income of Mayinglong Pharm, 2014-2018E
  • Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2011-2015
  • Revenue of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015
  • Revenue Structure of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015
  • Revenue of Shanghai Fosun Pharmaceutical (Group) by Region, 2011-2015
  • Revenue Structure of Shanghai Fosun Pharmaceutical (Group) by Region, 2011-2015
  • Gross Margin of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015
  • R&D Costs and % of Total Revenue of Shanghai Fosun Pharmaceutical (Group), 2012-2015
  • Number and Subscription Amount of Shares through Private Placement of Shanghai Fosun Pharmaceutical (Group), 2015
  • Medical Service Revenue and % of Total of Shanghai Fosun Pharmaceutical (Group), 2011-2015
  • Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2014-2018E
  • Revenue and Net Income of Jinling Pharmaceutical, 2011-2015
  • Revenue of Jinling Pharmaceutical by Product, 2011-2015
  • Revenue Structure of Jinling Pharmaceutical by Product, 2011-2015
  • Revenue of Jinling Pharmaceutical by Region, 2012-2015
  • Revenue Structure of Jinling Pharmaceutical by Region, 2012-2015
  • Gross Margin of Jinling Pharmaceutical by Product, 2011-2015
  • R&D Costs and % of Total Revenue of Jinling Pharmaceutical, 2012-2015
  • Medical Service Revenue and % of Total of Jinling Pharmaceutical, 2011-2015
  • Revenue and Net Income of Jinling Pharmaceutical, 2014-2018E
  • Revenue and Net Income of Shinva Medical, 2011-2015
  • Revenue of Shinva Medical by Product, 2011-2015
  • Revenue Structure of Shinva Medical by Product, 2011-2015
  • Revenue of Shinva Medical by Region, 2011-2015
  • Revenue Structure of Shinva Medical by Region, 2011-2015
  • Gross Margin of Shinva Medical by Product, 2011-2015
  • R&D Costs and % of Total Revenue of Shinva Medical, 2012-2014
  • Revenue and Net Income of Shinva Medical, 2014-2018E
  • Revenue and Net Income of Xi'an International Medical Investment, 2011-2015
  • Revenue of Xi'an International Medical Investment by Segment, 2012-2015
  • Revenue Structure of Xi'an International Medical Investment by Segment, 2012-2015
  • Revenue of Xi'an International Medical Investment by Region, 2011-2015
  • Revenue Structure of Xi'an International Medical Investment by Region, 2011-2015
  • Medical Service Revenue and % of Total of Xi'an International Medical Investment, 2012-2015
  • Revenue and Net Income of Xi'an International Medical Investment, 2011-2015
  • Issue Objects for the Private Placement, Their Placement Shares, and Subscription Amount of Xi'an International Medical Investment, 2015
  • Revenue and Net Income of Xi'an International Medical Investment, 2014-2018E
  • Revenue and Net Income of Inner Mongolia Furui Medical Science, 2011-2015
  • Revenue of Inner Mongolia Furui Medical Science by Product, 2011-2015
  • Revenue Structure of Inner Mongolia Furui Medical Science by Product, 2011-2015
  • Revenue and Net Income of Inner Mongolia Furui Medical Science, 2014-2018E
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp., 2011-2015
  • Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. by Segment, 2012-2015
  • Revenue Structure of Wuhan Jianmin Pharmaceutical Groups Corp. by Segment, 2012-2015 .
  • Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. by Region, 2011-2015
  • Revenue Structure of Wuhan Jianmin Pharmaceutical Groups Corp. by Region, 2011-2015
  • Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp., 2014-2018E
  • Revenue and Net Income of Concord Medical Services Holdings Limited, 2011-2015
  • Coverage of Service Network of Concord Medical Services Holdings Limited
  • Revenue and Net Income of Concord Medical Services Holdings Limited, 2014-2018E
  • Revenue and Net Income of Phoenix Healthcare Group, 2011-2015
  • General Hospital Service Revenue and YoY Growth of Phoenix Healthcare Group, 2011-2015
  • Hospital Management Service Revenue Structure of Phoenix Healthcare Group by Hospital, 2014
  • Revenue and Net Income of Phoenix Healthcare Group, 2014-2018E
  • Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2011-2015
  • Medical Service Revenue and % of Total of Guizhou Yibai Pharmaceutical, 2011-2015
  • Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2014-2018E
  • Revenue and Net Income of Kangmei Pharmaceutical, 2011-2015
  • Revenue and Net Income of Kangmei Pharmaceutical, 2014-2018E
  • Revenue and Net Income of JNMPT, 2011-2015
  • Revenue and Net Income of JNMPT, 2014-2018E
  • Revenue and Net Income of China Resources Sanjiu Medical & Pharmaceutical Co., 2011-2015
  • Medical Service Revenue and YoY Growth of China Resources Sanjiu Medical & Pharmaceutical Co., 2009-2013
  • Parkway Pantai Medical's Centers and Services in China

Related Companies

  • Aier Eye Hospital Group Co.,Ltd.(300015.SZ)
  • Topchoice Medical Investment Co.,Inc.(600763.SH)
  • MaYingLong Pharmaceutical Group Co.,Ltd.(600993.SH)
  • Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196.SH)
  • Jinling Pharmaceutical Company Limited(000919.SZ)
  • Shinva Medical Instrument Co.,Ltd.(600587.SH)
  • Xian Kaiyuan Investment Group Company Limited(000516.SZ)
  • Inner Mongolia Free Han and Mongolia Pharmaceutical Co., Ltd.(300049.SZ)
  • Wuhan Jianmin Pharmaceutical Group Co.,Ltd.(600976.SH)
  • Concord Medical Services Holdings Limited(CCM.NYSE)
  • Phoenix medical group(01515.SH)
  • Guizhou Yibai Pharmaceutical Co.,Ltd.(600594.SH)
  • Kangmei Pharmaceutical Co., Ltd.(600518.SH)
  • Jiangnan Mould & Plastic Technology Co.,Ltd.(000700.SZ)
  • China Resources Sanjiu Medical and Pharmaceutical Co., Ltd.(000999.SZ)
Back to Top